Long-term cellular and humoral responses to SARS-CoV-2 vaccinations in patients with solid malignancies undergoing chemotherapy.

Saved in:
Bibliographic Details
Title: Long-term cellular and humoral responses to SARS-CoV-2 vaccinations in patients with solid malignancies undergoing chemotherapy.
Authors: Liu A; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, United States., Necela B; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, United States., Li Z; Division of Quantitative Health Science, Mayo Clinic, Jacksonville, FL, United States., Cogen D; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, United States., Wieczorek MA; Division of Quantitative Health Science, Mayo Clinic, Jacksonville, FL, United States., Mummareddy A; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, United States., Acampora M; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, United States., Reynolds GA; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, United States., Advani PP; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, United States., Moreno-Aspitia A; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, United States., Swift MD; Department of Preventive, Occupational and Aerospace Medicine, Mayo Clinic, Jacksonville, FL, United States., Virk A; Division of Infectious Disease, Mayo Clinic, Jacksonville, FL, United States., Bharucha AE; Division of Gastroenterology & Hepatology, Mayo Clinic, Jacksonville, FL, United States., Marquez CP; Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL, United States., Patel TC; Division of Gastroenterology & Hepatology, Mayo Clinic, Jacksonville, FL, United States., Knutson KL; Department of Immunology, Mayo Clinic, Jacksonville, FL, United States., Chumsri S; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, United States.
Source: Frontiers in immunology [Front Immunol] 2026 Jan 29; Vol. 16, pp. 1690495. Date of Electronic Publication: 2026 Jan 29 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2025.1690495